by innovamemphis | Oct 20, 2008 | News
arGentis Pharmaceuticals LLC is gaining momentum to get its first two therapies to the marketplace with a $10 million-$12 million capital campaign, new paths for clinical trials and a renowned business accelerator firm to help it find a drug development partner. The...
by innovamemphis | Sep 1, 2008 | News
Innova Memphis Inc. has made its second investment, this time in Vaxent, a Memphis-based vaccine development company. Innova president Ken Woody would not disclose the size of the investment in Vaxent, but called it a “major play for us.” “Vaxent presents a tremendous...
by innovamemphis | Sep 1, 2008 | News
Innova Memphis Inc. has made its second investment, this time in Vaxent, a Memphis-based vaccine development company. Innova president Ken Woody would not disclose the size of the investment in Vaxent, but called it a “major play for us.” “Vaxent presents a tremendous...
